Sacroiliac joint fusion
Sacroiliac joint fusion is a surgical treatment sometimes used to address pain that may be originating from the joint between bones in the spine and hip (sacrum and ilium). The sacroiliac joint (SIJ) is a diarthrodial joint with two surfaces and a fibrous capsule containing synovial fluid.
Sacroiliac joint fusion was first reviewed by the HTA program in 2019.
- In 2020, a review of sacroiliac joint fusion medical literature was conducted to determine if newly available published evidence could change the original coverage determination.
- In 2021, the HCA director selected sacroiliac joint fusion for rereview based on newly available published evidence that could change the original coverage determination.
Status: Decision completed
Why is sacroiliac joint fusion being reviewed?
The Washington Health Technology Assessment program (HTA) selected Sacroiliac joint fusion as a topic for assessment because of high concerns for safety, efficacy and cost.
Primary criteria ranking
- Safety = High
- Efficacy = High
- Cost = High
Documentation
| Type | Materials |
|---|---|
| Assessment (2021) | |
| Update literature (2020) | |
| Assessment (2019) |
Assessment timeline
-
Draft key questions published: January 26, 2021
-
Public comment period: January 26 to February 11, 2021
-
-
Final key questions published: February 25, 2021
-
Draft report published: April 2, 2021
-
Public comment period: April 2 to May 3, 2021
-
-
Final report published: May 19, 2021
-
HTCC public meeting: June 18, 2021